Article Details

Scholar Rock scoops $47M to trial SMA drug

Retrieved on: 2018-01-02 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

Scholar Rock scoops $47M to trial SMA drug. View article details on hiswai:

Excerpt

<div>That list includes <b>Polaris Partners</b>, Timothy Springer, ARCH Venture Partners, EcoR1 Capital and The Kraft Group. The syndicate's support gives Scholar Rock the means to start a phase 1 trial of SRK-015. Scholar Rock has taken longer than expected to reach this point. In 2015, the startup had its sights ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up